AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NASDAQ:RVMDBill.com News Headlines

$31.43
-2.20 (-6.54 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$30.11
Now: $31.43▼
$35.69
50-Day Range
$20.85
MA: $29.94▼
$37.95
52-Week Range
$17.34
Now: $31.43▼
$47.14
Volume134,278 shs
Average Volume326,097 shs
Market Capitalization$1.85 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Bill.com (NASDAQ RVMD) News Headlines

Source:
DateHeadline
Bill.com (NASDAQ:RVMD) Given "Buy" Rating at HC WainwrightBill.com (NASDAQ:RVMD) Given "Buy" Rating at HC Wainwright
www.americanbankingnews.com - May 27 at 8:41 AM
Bill.com (NASDAQ:RVMD) Research Coverage Started at HC WainwrightBill.com (NASDAQ:RVMD) Research Coverage Started at HC Wainwright
www.americanbankingnews.com - May 21 at 11:37 AM
Bill.com (NASDAQ:RVMD) Issues Earnings Results, Misses Expectations By $0.41 EPSBill.com (NASDAQ:RVMD) Issues Earnings Results, Misses Expectations By $0.41 EPS
www.americanbankingnews.com - May 15 at 4:04 PM
Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate ProgressRevolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress
finance.yahoo.com - May 14 at 5:52 PM
Bill.com Holdings (NASDAQ:RVMD) Given Consensus Rating of "Buy" by BrokeragesBill.com Holdings (NASDAQ:RVMD) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 11 at 3:39 PM
Bill.com Holdings, Inc. (BILL) Q3 2020 Earnings Call TranscriptBill.com Holdings, Inc. (BILL) Q3 2020 Earnings Call Transcript
www.fool.com - May 8 at 2:23 PM
Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer ModelsRevolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
finance.yahoo.com - April 29 at 10:53 AM
New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer InstituteNew Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute
finance.yahoo.com - March 9 at 8:20 AM
Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesRevolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
www.marketwatch.com - February 20 at 8:42 PM
Revolution Medicines shares soar 85% in trading debut after IPO priced at top end of rangeRevolution Medicines shares soar 85% in trading debut after IPO priced at top end of range
finance.yahoo.com - February 20 at 10:40 AM
The Funded: 7 Bay Area startups raise over $135M at week's endThe Funded: 7 Bay Area startups raise over $135M at week's end
finance.yahoo.com - February 20 at 10:40 AM
Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesRevolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 20 at 10:40 AM
This page was last updated on 5/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.